Pharmacokinetics of flutamide in patients with renal insufficiency.
- Published in:
- British Journal of Clinical Pharmacology, 1999, v. 47, n. 1, doi. 10.1046/j.1365-2125.1999.00831.x
- By:
- Publication type:
- Article
Works matching IS 03065251 AND DT 1999 AND VI 47 AND IP 1
Results: 22
1
2
The pharmacokinetic modelling of GI198745 (dutasteride), a compound with parallel linear and nonlinear elimination.
- Published in:
- British Journal of Clinical Pharmacology, 1999, v. 47, n. 1, doi. 10.1046/j.1365-2125.1999.00843.x
- By:
- Publication type:
- Article
3
A study of the relative bioavailability of cysteamine hydrochloride, cysteamine bitartrate and phosphocysteamine in healthy adult male volunteers.
- Published in:
- British Journal of Clinical Pharmacology, 1999, v. 47, n. 1, doi. 10.1046/j.1365-2125.1999.00844.x
- By:
- Publication type:
- Article
4
A comparison of the use, effectiveness and safety of bezafibrate, gemfibrozil and simvastatin in normal clinical practice using the New Zealand Intensive Medicines Monitoring Programme (IMMP).
- Published in:
- British Journal of Clinical Pharmacology, 1999, v. 47, n. 1, doi. 10.1046/j.1365-2125.1999.00846.x
- By:
- Publication type:
- Article
5
The use of atypical antipsychotics in the management of schizophrenia.
- Published in:
- British Journal of Clinical Pharmacology, 1999, v. 47, n. 1, doi. 10.1046/j.1365-2125.1999.00849.x
- By:
- Publication type:
- Article
6
The therapeutic monitoring of antimicrobial agents.
- Published in:
- British Journal of Clinical Pharmacology, 1999, v. 47, n. 1, doi. 10.1046/j.1365-2125.1999.00850.x
- By:
- Publication type:
- Article
7
Vasoconstriction in human isolated middle meningeal arteries: determining the contribution of 5-HT[sub 1B]- and 5-HT[sub 1F]-receptor activation.
- Published in:
- British Journal of Clinical Pharmacology, 1999, v. 47, n. 1, doi. 10.1046/j.1365-2125.1999.00851.x
- By:
- Publication type:
- Article
8
The effects of age on human venous responsiveness to neuropeptide Y.
- Published in:
- British Journal of Clinical Pharmacology, 1999, v. 47, n. 1, doi. 10.1046/j.1365-2125.1999.00852.x
- By:
- Publication type:
- Article
9
Record-linkage for pharmacovigilance in Scotland.
- Published in:
- British Journal of Clinical Pharmacology, 1999, v. 47, n. 1
- By:
- Publication type:
- Article
10
Ketotifen and cardiovascular effects of xamoterol following single and chronic dosing in healthy volunteers.
- Published in:
- British Journal of Clinical Pharmacology, 1999, v. 47, n. 1, doi. 10.1046/j.1365-2125.1999.00854.x
- By:
- Publication type:
- Article
11
Cough and angiotensin II receptor antagonists: cause or confounding?
- Published in:
- British Journal of Clinical Pharmacology, 1999, v. 47, n. 1, doi. 10.1046/j.1365-2125.1999.00855.x
- By:
- Publication type:
- Article
12
Differential vascular α[sub 1]-adrenoceptor antagonism by tamsulosin and terazosin.
- Published in:
- British Journal of Clinical Pharmacology, 1999, v. 47, n. 1, doi. 10.1046/j.1365-2125.1999.00856.x
- By:
- Publication type:
- Article
13
Comparison of urinary 6β-hydroxycortisol/cortisol ratio between neonates and their mothers.
- Published in:
- British Journal of Clinical Pharmacology, 1999, v. 47, n. 1, doi. 10.1046/j.1365-2125.1999.00857.x
- By:
- Publication type:
- Article
14
Reliability of the omeprazole hydroxylation index for CYP2C19 phenotyping: possible effect of age, liver disease and length of therapy.
- Published in:
- British Journal of Clinical Pharmacology, 1999, v. 47, n. 1, doi. 10.1046/j.1365-2125.1999.00858.x
- By:
- Publication type:
- Article
15
Binding of propofol to blood components: implications for pharmacokinetics and for pharmacodynamics.
- Published in:
- British Journal of Clinical Pharmacology, 1999, v. 47, n. 1, doi. 10.1046/j.1365-2125.1999.00860.x
- By:
- Publication type:
- Article
16
CYP2D6 polymorphism in a Gabonese population: contribution of the CYP2D6*2 andCYP2D6*17 alleles to the high prevalence of the intermediate metabolic phenotype.
- Published in:
- British Journal of Clinical Pharmacology, 1999, v. 47, n. 1, doi. 10.1046/j.1365-2125.1999.00861.x
- By:
- Publication type:
- Article
17
Role of nitric oxide in isoprenaline and sodium nitroprusside-induced relaxation in human hand veins.
- Published in:
- British Journal of Clinical Pharmacology, 1999, v. 47, n. 1, doi. 10.1046/j.1365-2125.1999.00863.x
- By:
- Publication type:
- Article
18
BJCP 25th anniversary.
- Published in:
- British Journal of Clinical Pharmacology, 1999, v. 47, n. 1, doi. 10.1046/j.1365-2125.1999.00904.x
- By:
- Publication type:
- Article
19
Green into silver.
- Published in:
- British Journal of Clinical Pharmacology, 1999, v. 47, n. 1, doi. 10.1046/j.1365-2125.1999.00906.x
- By:
- Publication type:
- Article
20
Clinical pharmacology and drug regulation.
- Published in:
- British Journal of Clinical Pharmacology, 1999, v. 47, n. 1, doi. 10.1046/j.1365-2125.1999.00907.x
- By:
- Publication type:
- Article
21
Drug discovery and development in the molecular era.
- Published in:
- British Journal of Clinical Pharmacology, 1999, v. 47, n. 1, doi. 10.1046/j.1365-2125.1999.00908.x
- By:
- Publication type:
- Article
22
How will knowledge of the human genome affect drug therapy?
- Published in:
- British Journal of Clinical Pharmacology, 1999, v. 47, n. 1
- By:
- Publication type:
- Article